LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAD0. A total of 23 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $10,615,000 | +23.9% | 4,851,000 | +3.2% | 0.00% | +50.0% |
| Q4 2017 | $8,565,000 | -4.0% | 4,701,000 | -3.9% | 0.00% | 0.0% |
| Q3 2017 | $8,923,000 | -5.7% | 4,891,000 | -14.4% | 0.00% | 0.0% |
| Q2 2017 | $9,460,000 | +2.8% | 5,716,000 | -7.5% | 0.00% | 0.0% |
| Q1 2017 | $9,204,000 | -4.5% | 6,177,000 | -7.5% | 0.00% | -33.3% |
| Q4 2016 | $9,640,000 | +146.7% | 6,677,000 | +149.4% | 0.00% | +200.0% |
| Q3 2016 | $3,907,000 | -15.6% | 2,677,000 | -3.6% | 0.00% | -50.0% |
| Q2 2016 | $4,631,000 | +9.4% | 2,777,000 | 0.0% | 0.00% | +100.0% |
| Q1 2016 | $4,233,000 | +54.4% | 2,777,000 | +56.3% | 0.00% | 0.0% |
| Q4 2015 | $2,741,000 | +661.4% | 1,777,000 | +541.5% | 0.00% | – |
| Q3 2015 | $360,000 | – | 277,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opera Trading Capital | 5,700,000 | $8,208,000 | 2.47% |
| TFG Asset Management GP Ltd | 8,100,000 | $11,729,000 | 2.33% |
| Mint Tower Capital Management B.V. | 4,500,000 | $6,507,000 | 2.17% |
| BASSO CAPITAL MANAGEMENT, L.P. | 8,010,000 | $11,584,000 | 1.75% |
| CQS Cayman LP | 15,000,000 | $21,717,000 | 1.72% |
| LINDEN ADVISORS LP | 21,855,000 | $31,633,000 | 1.23% |
| CAMDEN ASSET MANAGEMENT L P /CA | 22,575,000 | $32,593,000 | 0.92% |
| Myriad Asset Management Ltd. | 9,000,000 | $13,045,000 | 0.90% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 25,000,000 | $36,172,000 | 0.64% |
| CSS LLC/IL | 5,500,000 | $7,955,000 | 0.43% |